GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ALGN · Jun 30, 2026

ALIGN TECHNOLOGY INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001097149-26-000060General Corporate
Capex intensity75thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.38% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

18.25% · OPTIONAL · VALID

Revenue growth88thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

4.32% · CORE · VALID

Inventory pressure25thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

20.09% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_margin

71.71% · CORE · VALID

Operating margin42thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

14.58% · CORE · VALID

R&D intensity92thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

9.66% · OPTIONAL · VALID

SBC intensity42thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

4.31% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building
Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Increased
Previous
2.96%
Current
3.38%
Delta
0.42%
Cash Generation Increased
Previous
14.52%
Current
18.25%
Delta
3.73%
Growth Decreased
Previous
6.21%
Current
4.32%
Delta
-1.89%
Inventory Pressure Decreased
Previous
20.67%
Current
20.09%
Delta
-0.57%
Margin Increased
Previous
70.82%
Current
71.71%
Delta
0.89%
Profitability Increased
Previous
13.65%
Current
14.58%
Delta
0.93%
R And D Intensity Increased
Previous
9.49%
Current
9.66%
Delta
0.17%
Sbc Intensity Increased
Previous
3.93%
Current
4.31%
Delta
0.38%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Orthopedic, Prosthetic & Surgical Appliances & Supplies peers →Has State · ALIGN TECHNOLOGY INC →Transitioned To · ALGN Fundamental State →Transitioned To · ALGN CAPEX_INTENSITY_INCREASED →Transitioned To · ALGN CASH_GENERATION_INCREASED →Transitioned To · ALGN GROWTH_DECREASED →Transitioned To · ALGN INVENTORY_PRESSURE_DECREASED →Transitioned To · ALGN MARGIN_INCREASED →Transitioned To · ALGN PROFITABILITY_INCREASED →Transitioned To · ALGN R_AND_D_INTENSITY_INCREASED →Transitioned To · ALGN SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.